Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss

Trial Profile

Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2013

At a glance

  • Drugs Dutasteride (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Apr 2013 New trial record
    • 17 Mar 2013 Results presented at the 28th Congress of the European Association of Urology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top